Displaying 1–2 of 2 results for Daniel Alsmeyer and Ajay Pazhayattil, Apotex Inc

Sort By Relevance Sort By Date

A New Day for Process Validation and Regulatory Review

(Article)

Drug Approval Strategies in the Age of Fast Track, Breakthrough Therapy and Accelerated Approval

A Case for Stage 3 Continued Process Verification

(Article)

Reducing process related failures and quality costs; Continued Process Verification can improve control and lower failure rates

Sort By Relevance Sort By Date